4.5 Article

CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis

Journal

FEBS LETTERS
Volume 587, Issue 12, Pages 1731-1735

Publisher

WILEY
DOI: 10.1016/j.febslet.2013.04.046

Keywords

Chemokine; CXCL14; CXCL12; CXCR4

Funding

  1. JSPS KAKENHI [23390256, 23659481, 22791043]
  2. MEXT KAKENHI [23126528]
  3. Mitsubishi Foundation
  4. Grants-in-Aid for Scientific Research [23659055, 23390256, 23126528, 23659481, 12J08863, 22791043] Funding Source: KAKEN

Ask authors/readers for more resources

Activation of the CXCL12-CXCR4 pathway is crucial for the migration of hematopoietic stem cells, various immune cells, and malignant tumor cells. Here, we show that another CXC chemokine, CXCL14, specifically binds to CXCR4 with high affinity and inhibits the CXCL12-mediated chemotaxis of human leukemia-derived cell lines and CD34(+) hematopoietic progenitor cells. Thus, CXCL14 functions as a natural inhibitor of CXCL12. Our observations suggest that CXCL14 represents, along with CXCR7, molecules that co-evolved with the CXCL12-CXCR4 axis to modulate important physiological processes in development, stem cell maintenance, and immune responses. Structured summary of protein interactions: CXCR4 physically interacts with CXCL14 anti bait coimmunoprecipitation by (View interaction). (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available